BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 4180999)

  • 1. The immunoglobulins: a review.
    Martin NH
    J Clin Pathol; 1969 Mar; 22(2):117-31. PubMed ID: 4180999
    [No Abstract]   [Full Text] [Related]  

  • 2. [The structure of normal and pathological human immunoglobulins].
    Seligmann M
    Presse Med (1893); 1967 Oct; 75(45):2243-4. PubMed ID: 4168455
    [No Abstract]   [Full Text] [Related]  

  • 3. The human serum immunoglobulins.
    Mattioli C; Tomasi TB
    Dis Mon; 1970 Apr; ():1-35. PubMed ID: 4192345
    [No Abstract]   [Full Text] [Related]  

  • 4. The frequency distribution of heavy chain classes and light chain types of 1,000 monoclonal immunoglobulins.
    Creyssel R; Gibaud A; Cordier JF; Boissel JP
    Biomedicine; 1975 Jan; 22(1):41-8. PubMed ID: 810190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surface bound immunoglobulins as a cell marker in human lymphoproliferative diseases.
    Preud'homme JL; Seligmann M
    Blood; 1972 Dec; 40(6):777-94. PubMed ID: 4628444
    [No Abstract]   [Full Text] [Related]  

  • 6. Immunoglobulin disturbances and their clinical significance.
    Solomon A; McLaughlin CL
    Med Clin North Am; 1973 Mar; 57(2):499-516. PubMed ID: 4632920
    [No Abstract]   [Full Text] [Related]  

  • 7. B-cell neoplasia in man.
    Salmon SE; Seligmann M
    Lancet; 1974 Nov; 2(7891):1230-3. PubMed ID: 4139472
    [No Abstract]   [Full Text] [Related]  

  • 8. Significance of M-components in plasma cell myeloma and related disorders.
    Kano T
    Tohoku J Exp Med; 1970 Dec; 102(4):341-67. PubMed ID: 4101555
    [No Abstract]   [Full Text] [Related]  

  • 9. [Studies of cell content and surface and secretory immunoglobulins in myeloma, macroglobulinemia, malignant lymphoma and related leukemic diseases].
    Miyoshi K; Kosaka M; Tamora R; Numata Y; Takamato M
    Nihon Rinsho; 1976 May; 34(5):945-53. PubMed ID: 824476
    [No Abstract]   [Full Text] [Related]  

  • 10. [Combined features of mu-heavy chain disease and primary macroglobulinemia in a single patient: clinical and immunological studies].
    Fujii H; Shimizu T; Seki S; Isemura T; Yamamoto K; Kanoh T; Ohno Y
    Nihon Ketsueki Gakkai Zasshi; 1982 May; 45(3):622-32. PubMed ID: 6814143
    [No Abstract]   [Full Text] [Related]  

  • 11. Pathophysiology of the monoclonal gammopathies. 1.
    Maldonado JE; Kyle RA; McDuffie FC; Linman JW
    Postgrad Med; 1973 Jun; 53(7):102-6. PubMed ID: 4122509
    [No Abstract]   [Full Text] [Related]  

  • 12. [Immunological aspects of malignant lymphoproliferative diseases].
    Rivero I; Diumenjo M
    Rev Clin Esp; 1977 Mar; 144(6):403-9. PubMed ID: 140441
    [No Abstract]   [Full Text] [Related]  

  • 13. Multiple anomalous immunoglobulins. Clinical, structural and cellular studies in three patients.
    Sanders JH; Fahey JL; Finegold I; Ein D; Reisfeld R; Berard C
    Am J Med; 1969 Jul; 47(1):43-59. PubMed ID: 4183355
    [No Abstract]   [Full Text] [Related]  

  • 14. The nature of myeloma proteins.
    Cohen S
    Br J Haematol; 1968 Sep; 15(3):211-5. PubMed ID: 4176098
    [No Abstract]   [Full Text] [Related]  

  • 15. Human anti-gamma-globulin antibodies specific for gamma G heavy chain subclasses.
    Natvig JB
    Immunology; 1970 Jul; 19(1):125-35. PubMed ID: 4098591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dysimmunoglobulinemia in the absence of clinical features of multiple myeloma and macroglobulinemia.
    Zawadzki ZA; Edwards GA
    Am J Med; 1967 Jan; 42(1):67-88. PubMed ID: 4163278
    [No Abstract]   [Full Text] [Related]  

  • 17. B and T cell markers in human proliferative blood diseases and primary immunodeficiencies, with special reference to membrane bound immunoglobulins.
    Seligmann M; Preud'Homme JL; Brouet JC
    Transplant Rev; 1973; 16():85-113. PubMed ID: 4204588
    [No Abstract]   [Full Text] [Related]  

  • 18. Frequency of monoclonal gammapathy ('M components') in 13,400 sera from blood donors.
    Fine JM; Lambin P; Leroux P
    Vox Sang; 1972; 23(4):336-43. PubMed ID: 4118149
    [No Abstract]   [Full Text] [Related]  

  • 19. [Reaction between the first component C1 of the complement system and immunoglobulins in relation to their class, subclass and physical condition].
    Augener W; Grey HM; Cooper NR; Müller-Eberhard HJ
    Verh Dtsch Ges Inn Med; 1971; 77():1163-5. PubMed ID: 5005546
    [No Abstract]   [Full Text] [Related]  

  • 20. [Immunochemical characterization of the L-chains and H-chains of monoclonal immunoglobulins in multiple myeloma, Waldenstrom's disease and heavy chain disease].
    Tischendorf FW
    Med Welt; 1968 Nov; 46():2531-6. PubMed ID: 4183339
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.